Table III. Multivariable analysis of PFS and OS for nivolumab.
PFS, Progression-free survival; OS, overall survival; HR, hazard ratio; CI, confidence interval; ECOG PS, Eastern Cooperative Oncology Group performance status; LDH, lactate dehydrogenase; GPS, Glasgow prognostic score; DCBC, disease control by chemotherapy prior to nivolumab.